Hypertension, 4th Edition
Hardcover
-
-
Thoroughly covers new treatment guidelines related to recent research and the latest physiologic understanding for a wide range of patients with hypertension and related co-morbidities.
-
Includes new chapters on Hypertension in Women, Mineralocorticoid Receptor Antagonists, Exercise and Hypertension, and Telemedicine/Digital Health.
-
Contains new or expanded content on epidemiology, pathophysiology, immunology, clinical findings, laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, prognosis, and management.
-
Provides new chapter summaries and a new focus on clinical and actionable content using a streamlined, narrative format.
-
Covers behavior management and prevention as an integral part of hypertensive and pre-hypertensive treatment plans.
-
Highlights combination drug therapies and management of chronic complications of hypertension.
-
Offers expert guidance from worldwide experts in cardiology, endocrinology, and nephrology, and integrates the most recent guidelines from leading organizations around the world.
-
An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud.
-
-
Tentative pending approval from Dr Braunwald
SECTION I: EPIDEMIOLOGY
1. General Population and Global Cardiovascular Risk Prediction
2. Hypertension in Latin/Hispanic Population
3. Hypertension in East Asians and Native Hawaiians
4. Hypertension in South Asians
5. Hypertension in Women - NEW
SECTION II: PATHOPHYSIOLOGY
6. Pathogenesis of Hypertension
7. Genetics of Hypertension
8. Inflammation and Immunity in Hypertension
SECTION III: DIAGNOSIS AND EVALUATION
9. Environmental Factors Affecting Blood Pressure Development
10. Office Blood Pressure Measurement
11. Home Monitoring of Blood Pressure
12. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management
13. White Coat and Masked Hypertension
14. Secondary Hypertension: Renovascular Hypertension
15. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States
16. Secondary Hypertension: Pheochromocytoma
17. Secondary Hypertension: Sleep Disturbances including Sleep Apnea
18. Hypertension in Children: Diagnosis and Treatment
SECTION IV: RISK STRATIFICATION
19. Natural History of Untreated Hypertension
20. Isolated Systolic Hypertension
21. Assessment of Target Organ Damage
SECTION V: ANTIHYPERTENSIVE THERAPY
22. Diet and Blood Pressure
23. Diuretic Therapy
24. Peripheral Adrenergic Blockers
25. Renin Angiotensin Aldosterone System Blockers
26. Calcium Channel Blockers
27. Central Sympathetic Agents and Direct Vasodilators
28. Mineralocorticoid Receptor Antagonists – NEW
29. Use of Combination Therapies
30. Devices Therapies
31. Alternative/Complementary Medicine
SECTION VI: HYPERTENSION MANAGEMENT
32. Approach to Uncomplicated Primary Hypertension
33. Ischemic Heart Disease
34. Heart Failure
35. Kidney Disease including Dialysis
36. Transplant Hypertension
37. Obesity
38. Cerebrovascular Disease
39. Diabetes Mellitus
40. Dyslipidemia
SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS
41. Hypertension in Pregnancy
42. Hypertension in Older People
43. Hypertension in African Americans
44. Baroreceptor Dysfunction/Orthostatic Hypotension
45. Resistant Hypertension
46. Hypertension and the Perioperative Period
47. Aorta and Peripheral Arterial Disease in Hypertension
48. Hypertensive Emergencies
49. Exercise and Hypertension - NEW
SECTION VIII: OUTCOME TRIALS
50. Meta-Analyses of Hypertension Trials: The Blood Pressure Lowering Treatment Trialists’ Collaboration
SECTION IX: HYPERTENSION TREATMENT IN THE FUTURE
51. Team-Based Care for Hypertension Management
52. Understanding and Improving Medication Adherence
53. Telemedicine and Digital Health for Hypertension Management - NEW
-
George L. Bakris, MD, Professor of Medicine, Director, Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, Illinois, Matthew Sorrentino, MD, Professor of Medicine, Associate Director, Bucksbaum Institute for Clinical Excellence, University of Chicago Medicine, Chicago, Illinois and Luke J. Laffin, MD, Co-Director, Center for Blood Pressure Disorders, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
as described in our 